News - Latest
96 news items
Sort by: Date / Relevance
Regulatory Science Magazine 11 on monitoring corona vaccines
The eleventh edition of the MEB’s Regulatory Science Magazine brings you interviews with Peter Mol, professor of Drug Regulatory ...
Year-end withdrawals medicines for human use
Requests to withdraw marketing authorisations and parallel import marketing authorisations as of 31 December 2020, the so-called ...
Conclusion of report: paracetamol is safe to use
Patients and consumers can continue to use paracetamol safely in the Netherlands. This is the conclusion of the Netherlands ...
Safety of paracetamol is not compromised
Tonight (Thursday July 9) the Dutch newspaper NRC and TV programme Zembla published an article on contamination of paracetamol ...
Coronavirus: consequences for applications for production and distribution licences, GMP inspections and certificates
Unfortunately, the current coronavirus situation is also having consequences for applications for licences for the manufacture ...
Implementation of the Medical Device Regulation postponed until 26 May 2021
Due to the coronavirus crisis the European Commission has postponed the implementation of the new Medical Device Regulation (MDR, ...
Veterinary Medicinal Products Unit: submit your application digitally
The Veterinary Medicinal Products Unit (VMPU) requests marketing authorisation holders to submit their applications or reports ...
MEB Portal shut down permanently
For safety reasons, the MEB portal was provisionally taken offline in January this year. Unfortunately, the MEB has had to take ...
Request to take over the Fucidin marketing authorisation
The company Leo Pharma B.V. has informed the Medicines Evaluation Board (MEB) that the production of the antibiotic Fucidin ...
Request to take over the pyridoxine hydrochloride marketing authorisation
The company Pharmachemie B.V. has requested the Medicines Evaluation Board (MEB) to withdraw marketing authorisation for ...